Skip to Content

TEVA 7336 (Topiramate (Sprinkle) 25 mg)

Pill with imprint TEVA 7336 is White, Capsule-shape and has been identified as Topiramate (Sprinkle) 25 mg. It is supplied by Teva Pharmaceuticals USA.

Topiramate is used in the treatment of epilepsy; seizure prevention; lennox-gastaut syndrome; migraine prevention; seizures and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TEVA 7336

Topiramate (sprinkle) 25 mg TEVA 7336
Topiramate (sprinkle) 25 mg TEVA 7336
Topiramate (sprinkle) 25 mg TEVA 7336

Topiramate (Sprinkle)

Imprint
TEVA 7336
Strength
25 mg
Color
White
Size
19.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Carbonic anhydrase inhibitor anticonvulsants
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA
National Drug Code (NDC)
00093-7336

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.